NASDAQ:KRMD KORU Medical Systems (KRMD) Stock Price, News & Analysis → Move Your Money Before May 22 (From Stansberry Research) (Ad) Free KRMD Stock Alerts $2.19 0.00 (0.00%) (As of 04/26/2024 ET) Add Compare Share Share Today's Range$2.12▼$2.2250-Day Range$2.04▼$2.4952-Week Range$1.98▼$4.48Volume91,205 shsAverage Volume94,654 shsMarket Capitalization$100.10 millionP/E RatioN/ADividend YieldN/APrice Target$3.50 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get KORU Medical Systems alerts: Email Address KORU Medical Systems MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside59.8% Upside$3.50 Price TargetShort InterestBearish2.62% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.00Based on 2 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.15) to ($0.09) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.35 out of 5 starsMedical Sector648th out of 908 stocksSurgical & Medical Instruments Industry73rd out of 97 stocks 3.5 Analyst's Opinion Consensus RatingKORU Medical Systems has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageKORU Medical Systems has only been the subject of 1 research reports in the past 90 days. Previous Next 1.0 Short Interest Percentage of Shares Shorted2.62% of the float of KORU Medical Systems has been sold short.Short Interest Ratio / Days to CoverKORU Medical Systems has a short interest ratio ("days to cover") of 11.9, which indicates bearish sentiment.Change versus previous monthShort interest in KORU Medical Systems has recently increased by 9.52%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldKORU Medical Systems does not currently pay a dividend.Dividend GrowthKORU Medical Systems does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for KRMD. Previous Next 0.6 News and Social Media Coverage News Coverage This WeekMarketBeat has tracked 2 news articles for KORU Medical Systems this week, compared to 1 article on an average week.Search Interest3 people have searched for KRMD on MarketBeat in the last 30 days. This is an increase of 50% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added KORU Medical Systems to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, KORU Medical Systems insiders have not sold or bought any company stock.Percentage Held by Insiders25.60% of the stock of KORU Medical Systems is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions58.60% of the stock of KORU Medical Systems is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for KORU Medical Systems are expected to grow in the coming year, from ($0.15) to ($0.09) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of KORU Medical Systems is -7.55, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of KORU Medical Systems is -7.55, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioKORU Medical Systems has a P/B Ratio of 4.87. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Weiss RatingsProtect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late. About KORU Medical Systems Stock (NASDAQ:KRMD)KORU Medical Systems, Inc. develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The company was incorporated in 1980 and is based in Mahwah, New Jersey.Read More KRMD Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart KRMD Stock News HeadlinesApril 24, 2024 | americanbankingnews.comKORU Medical Systems (KRMD) Set to Announce Quarterly Earnings on WednesdayApril 22, 2024 | msn.comHeat face Celtics in first round after epic conference finals duel last seasonApril 26, 2024 | Stansberry Research (Ad)Move Your Money Before May 22The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals. April 17, 2024 | finance.yahoo.comKORU Medical Systems to Report First Quarter 2024 Financial Results on May 1, 2024April 16, 2024 | americanbankingnews.comShort Interest in KORU Medical Systems, Inc. (NASDAQ:KRMD) Expands By 5.6%April 11, 2024 | businesswire.comKORU Medical Systems Announces Successful Appeal in EU Notified Body ReviewMarch 28, 2024 | investorplace.comThe Penny Stock A-List: 7 High-Profile Companies on the Verge of GreatnessMarch 18, 2024 | businesswire.comKORU Medical Systems to Present Data Demonstrating 97% Adherence on Its Freedom Infusion System for Large Volume Subcutaneous Administration at NHIA 2024 ConferenceApril 26, 2024 | Stansberry Research (Ad)Move Your Money Before May 22The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals. March 17, 2024 | msn.comYankees get the World Series-winning crew back together to help out in spring trainingMarch 16, 2024 | finance.yahoo.comKORU Medical Systems, Inc. (NASDAQ:KRMD) Q4 2023 Earnings Call TranscriptMarch 15, 2024 | finance.yahoo.comKORU Medical Systems Full Year 2023 Earnings: EPS Misses ExpectationsMarch 14, 2024 | msn.comSaratoga County Sheriff’s Office to participate in statewide STOP-DWI St. Patrick’s Day campaignMarch 14, 2024 | markets.businessinsider.comBuy Rating Justified: REPRO-MED Systems’ Strong Growth Prospects and Solid Financial PerformanceMarch 14, 2024 | finance.yahoo.comKORU Medical Systems Inc (KRMD) Reports Mixed 2023 Financial Results and Provides 2024 OutlookMarch 13, 2024 | finance.yahoo.comKORU Medical Systems, Inc. Announces 2023 Fourth Quarter, Full Year Financial Results, and 2024 GuidanceMarch 12, 2024 | benzinga.comEarnings Outlook For KORU Medical SystemsMarch 11, 2024 | businesswire.comKORU Medical Systems Announces a Feasibility Study to Enter Ambulatory Infusion Settings with a Commercialized BiologicMarch 8, 2024 | markets.businessinsider.comCraig-Hallum Keeps Their Buy Rating on REPRO-MED Systems (KRMD)March 6, 2024 | markets.businessinsider.comBuy Rating Affirmed for KORU Medical Systems Amidst Growth and Market Expansion ProspectsMarch 6, 2024 | businesswire.comKORU Medical Systems Signs a Clinical Supply Agreement for Phase 3 Trial with Leading Pharma Partner Using Custom Device for a Novel Subcutaneous ImmunoglobulinFebruary 28, 2024 | morningstar.comKORU Medical Systems Inc KRMDFebruary 21, 2024 | finance.yahoo.comKORU Medical Systems to Report Fourth Quarter and Full Year 2023 Financial Results on March 13, 2024February 21, 2024 | businesswire.comKORU Medical Systems to Report Fourth Quarter and Full Year 2023 Financial Results on March 13, 2024February 16, 2024 | finance.yahoo.comRetail investors account for 39% of KORU Medical Systems, Inc.'s (NASDAQ:KRMD) ownership, while institutions account for 32%January 18, 2024 | msn.comSaratoga County Sheriff’s Deputies honored as Deputy of the YearDecember 13, 2023 | markets.businessinsider.comBuy Rating for KORU Medical Systems Amid Growth and Market Expansion OpportunitiesSee More Headlines Receive KRMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for KORU Medical Systems and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/13/2024Today4/26/2024Next Earnings (Confirmed)5/01/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:KRMD CUSIPN/A CIK704440 Webwww.korumedical.com Phone(845) 469-2042Fax845-469-5518Employees82Year FoundedN/APrice Target and Rating Average Stock Price Target$3.50 High Stock Price Target$4.00 Low Stock Price Target$3.00 Potential Upside/Downside+63.6%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)($0.29) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-13,740,000.00 Net Margins-48.18% Pretax Margin-34.27% Return on Equity-27.82% Return on Assets-21.30% Debt Debt-to-Equity Ratio0.02 Current Ratio4.55 Quick Ratio3.77 Sales & Book Value Annual Sales$28.52 million Price / Sales3.43 Cash FlowN/A Price / Cash FlowN/A Book Value$0.45 per share Price / Book4.76Miscellaneous Outstanding Shares45,710,000Free Float34,008,000Market Cap$97.82 million OptionableOptionable Beta0.53 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMs. Linda M. Tharby (Age 56)President, CEO & Director Comp: $713.37kMr. Thomas Adams (Age 51)CFO, Secretary & Treasurer Comp: $380.47kMr. Brian Case (Age 51)Chief Technology Officer Comp: $371.16kMr. Kenneth Miller (Age 55)Chief Commercial Officer Comp: $126.54kMr. Christopher PazdanSenior Vice President of OperationsMr. Rob CannonVice President of SalesMore ExecutivesKey CompetitorsBlueRiver AcquisitionNYSE:BLUAAllurion TechnologiesNYSE:ALURTELA BioNASDAQ:TELABrainsWayNASDAQ:BWAYNeuroneticsNASDAQ:STIMView All CompetitorsInsiders & InstitutionsMesirow Financial Investment Management Inc.Bought 10,959 shares on 4/26/2024Ownership: 0.024%Albion Financial Group UTSold 27,500 shares on 4/19/2024Ownership: 1.622%Advisor Resource CouncilBought 25,500 shares on 4/19/2024Ownership: 0.056%First Light Asset Management LLCSold 123,559 shares on 2/14/2024Ownership: 11.307%Bard Associates Inc.Bought 4,910 shares on 2/13/2024Ownership: 0.058%View All Insider TransactionsView All Institutional Transactions KRMD Stock Analysis - Frequently Asked Questions Should I buy or sell KORU Medical Systems stock right now? 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for KORU Medical Systems in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" KRMD shares. View KRMD analyst ratings or view top-rated stocks. What is KORU Medical Systems' stock price target for 2024? 4 Wall Street research analysts have issued 12-month price targets for KORU Medical Systems' shares. Their KRMD share price targets range from $3.00 to $4.00. On average, they predict the company's stock price to reach $3.50 in the next year. This suggests a possible upside of 59.8% from the stock's current price. View analysts price targets for KRMD or view top-rated stocks among Wall Street analysts. How have KRMD shares performed in 2024? KORU Medical Systems' stock was trading at $2.46 at the beginning of 2024. Since then, KRMD stock has decreased by 11.0% and is now trading at $2.19. View the best growth stocks for 2024 here. Are investors shorting KORU Medical Systems? KORU Medical Systems saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 1,050,000 shares, an increase of 5.6% from the March 15th total of 994,500 shares. Based on an average daily volume of 95,500 shares, the short-interest ratio is currently 11.0 days. View KORU Medical Systems' Short Interest. When is KORU Medical Systems' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 1st 2024. View our KRMD earnings forecast. How can I listen to KORU Medical Systems' earnings call? KORU Medical Systems will be holding an earnings conference call on Wednesday, May 1st at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link. How were KORU Medical Systems' earnings last quarter? KORU Medical Systems, Inc. (NASDAQ:KRMD) posted its quarterly earnings results on Wednesday, March, 13th. The company reported ($0.02) earnings per share for the quarter, beating analysts' consensus estimates of ($0.04) by $0.02. The firm earned $7.19 million during the quarter, compared to analysts' expectations of $7.01 million. KORU Medical Systems had a negative trailing twelve-month return on equity of 27.82% and a negative net margin of 48.18%. What guidance has KORU Medical Systems issued on next quarter's earnings? KORU Medical Systems updated its FY 2024 earnings guidance on Wednesday, March, 13th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $31.2 million-$32.2 million, compared to the consensus revenue estimate of $32.3 million. What other stocks do shareholders of KORU Medical Systems own? Based on aggregate information from My MarketBeat watchlists, some companies that other KORU Medical Systems investors own include NVIDIA (NVDA), Enphase Energy (ENPH), Alibaba Group (BABA), Walt Disney (DIS), PennyMac Financial Services (PFSI), Inseego (INSG), Micron Technology (MU), Advanced Micro Devices (AMD), Marvell Technology (MRVL) and Taiwan Semiconductor Manufacturing (TSM). Who are KORU Medical Systems' major shareholders? KORU Medical Systems' stock is owned by a number of retail and institutional investors. Top institutional shareholders include Albion Financial Group UT (1.62%), Advisor Resource Council (0.06%) and Mesirow Financial Investment Management Inc. (0.02%). Insiders that own company stock include James M Beck, Joseph M Jr Manko, Linda M Tharby and Robert Cascella. View institutional ownership trends. How do I buy shares of KORU Medical Systems? Shares of KRMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:KRMD) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersFed launches fourth dollar overhaulStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”AltimetryJim Cramer’s “The Biggest Drug Ever”Behind the MarketsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsThe AI stock to buy right nowStockEarnings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding KORU Medical Systems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
